Updated phase 3 data support pembrolizumab plus concurrent chemoradiotherapy as a standard of care for patients with high-risk, locally advanced cervical cancer, according to Linda Duska, MD.

A recent AIIMS, Delhi study reveals that removing specific lymph nodes from the pelvis and abdomen significantly improves ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

STEPH Washington was diagnosed with stage four cancer after medics dismissed her symptoms as a STI for a year – and she doesn ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.

Ovarian Cancer: "This is a challenging procedure as the main vessels related to the heart are all around lymph nodes and so ...

I don't want to be explaining to my daughters why we've still failed to make progress on gynaecological cancers, writes Elise ...

As 19 women are diagnosed with a gynaecological cancer every day, advocates are calling for more funding to improve ...

TGH Onco-Life Cancer Centre, with support from Rotary Club and POSCO India, has launched a mobile cancer screening van in ...

Rural populations face unique challenges in cancer prevention and care. Geographic isolation, economic constraints, and a ...

A study by AIIMS found that removing the lymph nodes from the pelvis and rear abdominal walls can significantly improve the survival chances of ovarian cancer patients. Read on to know more about the ...